OTC Markets EXMKT USD

Item 9 Labs Corp. (INLB)

0.0001 0.0000 (0.00%)
At close: May 30 at 9:30 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Total Revenue
19,690.7390
21,756.9970
21,937.2270
8,121.7330
4,933.9600
Cost of Revenue
9,886.1470
14,445.2690
13,324.2840
4,825.9590
2,556.1890
Gross Profit
9,804.5920
7,311.7280
8,612.9430
3,295.7740
2,377.7710
Operating Expense
19,849.0450
20,431.9380
14,214.2060
8,621.7240
6,759.9830
Operating Income
-10,044.4530
-13,120.2100
-5,601.2630
-5,325.9500
-4,382.2120
Net Non Operating Interest Income Expense
-9,201.2370
-6,414.5300
-5,295.3490
-6,959.7050
-271.3420
Other Income Expense
-11,796.4960
-11,631.0920
-9.1600
-99.9860
-5,295.0840
Pretax Income
-31,042.1860
-31,165.8320
-10,905.7720
-12,385.6410
-9,948.6380
Tax Provision
11.1970
13.2210
--
-85.9840
--
Net Income Common Stockholders
-31,034.6340
-31,142.6040
-10,905.7720
-12,273.3830
-9,824.6960
Diluted NI Available to Com Stockholders
-31,034.6340
-31,142.6040
-10,905.7720
-12,273.3830
-9,824.6960
Basic EPS
-0.33
-0.33
-0.14
-0.20
-0.16
Diluted EPS
-0.33
-0.33
-0.14
-0.20
-0.16
Basic Average Shares
99,529.9380
95,690.7090
78,592.8890
61,621.9550
61,531.8020
Diluted Average Shares
99,529.9380
95,690.7090
78,592.8890
61,621.9550
61,531.8020
Total Operating Income as Reported
-20,158.0480
-23,065.2340
-5,601.2630
-5,425.9500
-10,141.0390
Total Expenses
29,735.1920
34,877.2070
27,538.4900
13,447.6830
9,316.1720
Net Income from Continuing & Discontinued Operation
-31,034.6340
-31,142.6040
-10,905.7720
-12,273.3830
-9,824.6960
Normalized Income
-21,712.6490
-21,953.7901
-10,905.7720
-12,174.0772
-4,065.8690
Interest Income
--
--
--
--
71.3760
Interest Expense
9,201.2370
6,414.5300
5,295.3490
6,959.7050
342.7180
Net Interest Income
-9,201.2370
-6,414.5300
-5,295.3490
-6,959.7050
-271.3420
EBIT
-21,840.9490
-24,751.3020
-5,610.4230
-5,425.9360
-9,605.9200
EBITDA
-20,010.7920
-22,829.1020
-4,349.7580
-4,446.7780
-8,929.7860
Reconciled Cost of Revenue
9,477.6960
14,129.9200
13,149.4660
4,754.3570
2,555.7100
Reconciled Depreciation
1,830.1570
1,922.2000
1,260.6650
979.1580
676.1340
Net Income from Continuing Operation Net Minority Interest
-31,034.6340
-31,142.6040
-10,905.7720
-12,273.3830
-9,824.6960
Total Unusual Items Excluding Goodwill
-11,799.9810
-11,631.4100
--
-100.0000
-5,758.8270
Total Unusual Items
-11,799.9810
-11,631.4100
--
-100.0000
-5,758.8270
Normalized EBITDA
-8,210.8110
-11,197.6920
-4,349.7580
-4,346.7780
-3,170.9590
Tax Rate for Calcs
0.0002
0.0002
--
0.0000
--
Tax Effect of Unusual Items
-2,477.9960
-2,442.5961
--
-0.6942
--
9/30/2019 - 1/25/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

STMH Stem Holdings, Inc.
0.0305
0.00%
 
BSPM Biostar Pharmaceuticals, Inc.
0.0000
-86.00%
 
PAIOF Paion AG
0.0500
0.00%
 
HSTI High Sierra Technologies, Inc.
1.3000
0.00%
 
BOIRF Boiron SA
39.10
0.00%
 
BIOIF Biome Grow Inc.
0.0031
0.00%
 
VIVXF Avivagen Inc.
0.0012
0.00%
 
VFRM Veritas Farms, Inc.
0.0150
0.00%
 
LTTSF Lotus Ventures Inc.
0.0051
0.00%
 
CSTF CuraScientific Corp.
0.0001
0.00%